Related Experiment Video

Updated: Jun 12, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

[Cancer treatment by comprehensive regulation of anti-tumor immune network]

Yutaka Kawakami1

  • 1Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 12, 2010
PubMed

Insights

Current cancer vaccines show limited anti-tumor effects. Improving cancer immunotherapy requires targeting tumor antigens, enhancing antigen presentation, expanding T cells, and overcoming immunosuppression for effective immunological tumor rejection.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Current cancer vaccines exhibit restricted anti-tumor efficacy.
  • Clinical trial analyses highlight key areas for enhancing anti-tumor immunity.

Purpose of the Study:

  • To identify critical improvements for effective cancer immunotherapy.
  • To outline strategies for overcoming limitations in current cancer vaccine approaches.

Main Methods:

  • Review and analysis of clinical trial data for cancer vaccines.
  • Identification of key immunological targets and mechanisms.

Main Results:

  • Essential improvements include identifying tumor antigens in cancer stem cells.
  • Developing in situ tumor destruction for immunogenic antigen release.
  • Augmenting antigen processing and presentation by dendritic cells.
  • Expanding T cells in vivo and overcoming cancer-induced immunosuppression.

Conclusions:

  • Comprehensive interventions in the anti-tumor immune network are crucial.
  • Addressing identified points will advance effective cancer immunotherapy and immunological tumor rejection.

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...